Colorectal cancer diagnosis

+How to treat

In print

Colorectal cancer diagnosis

12 April 2023

By Cameron Schauer

Wednesday 12 April 2023, 12:45 AM

[Image: Fraser Williamson]

This article, written by Cameron Schauer, highlights the fundamental role GPs play in colorectal cancer diagnosis. It covers the symptoms, signs and risk factors of CRC, then discusses investigations and interventions, including recommended surveillance and screening processes. It also looks to the future and how the efficiency of current diagnostic pathways might be improved

This How to Treat has been endorsed by the RNZCGP and has been approved for up to 1 credit for continuing professional development purposes (1 credit , Educate small, BACK panel - grey

How to Treat

Gastroenterology

Investigations

Oncology

References

Ministry of Health. Cancer: New Registrations and Deaths 2006. Wellington, NZ: Ministry of Health; 2010.
Ministry of Health. Cancer Projections: Incidence 2004–08 to 2014–18. Wellington, NZ: Ministry of Health; 2010.
Samson P, O’Grady G, Keating J. An international comparison study of stage of colorectal cancer at diagnosis: how does New Zealand compare? N Z Med J 2009;122(1294):74–83.
Te Aho o Te Kahu. He Pūrongo Mate Pukupuku o Aotearoa 2020, The State of Cancer in New Zealand 2020. Wellington, NZ: Te Aho o Te Kahu, Cancer Control Agency; 2021.
McLeod M, Harris R, Paine SJ, et al. Bowel cancer screening age range for Māori: what is all the fuss about? N Z Med J 2021;134(1535):71–77.
Sharples KJ, Firth MJ, Hinder et al. The New Zealand PIPER Project: colorectal cancer survival according to rurality, ethnicity and socioeconomic deprivation-results from a retrospective cohort study. N Z Med J 2018;131(1476):24–39.
Swart EM, Sarfati D, Cunningham R, et al. Ethnicity and rectal cancer management in New Zealand. N Z Med J 2013;126(1384):42–52.
Pitama S, Huria T, Lacey C. Improving Māori health through clinical assessment: Waikare o te Waka o Meihana. N Z Med J 2014;127(1393):107–19.
Pitama S, Cave T, Huria T, et al. Exploring Maori health worker perspectives on colorectal screening. N Z Med J 2012;125(1356):75–84.
Vega P, Valentín F, Cubiella J. Colorectal cancer diagnosis: Pitfalls and opportunities. World J Gastrointest Oncol 2015;7(12):422–33.
Schauer C, Wijesinghe U, Wang MT, et al. Improving efficiency of current diagnostic pathways for investigation of colorectal cancer in symptomatic patients. N Z Med J 2021;134(1530):123–25.
Clinical Governance Research and Development Unit, University of Leicester. Referral Guidelines for Suspected Cancer in Adults and Children. (NICE Clinical Guideline CG27) London, UK: Royal College of General Practitioners; 2005.
Hsiang JC, Bai W, Lal D. Symptom presentations and other characteristics of colorectal cancer patients and the diagnostic performance of the Auckland Regional Grading Criteria for Suspected Colorectal Cancer in the South Auckland population. N Z Med J 2013;126(1382):95–107.
Murray M, Brown J, Hinder V, et al. The colorectal cancer patients’ journey: the Auckland region. N Z Med J 2011;124(1331):18–28.
Health and Disability Commissioner. Delayed Diagnosis of Cancer in Primary Care: Complaints to the Health and Disability Commissioner: 2004-2013. Auckland, NZ: HDC; 2015.
Ang CW, Dawson R, Hall C, Farmer M. The diagnostic value of digital rectal examination in primary care for palpable rectal tumour. Colorectal Dis 2008;10(8):789–92.
Dunn JE. Cancer epidemiology in populations of the United States--with emphasis on Hawaii and California--and Japan. Cancer Res 1975;35(11 Pt. 2):3240–45.
Bishehsari F, Mahdavinia M, Vacca M, et al. Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol 2014;20(20):6055–72.
Richardson A, Hayes J, Frampton C, Potter J. Modifiable lifestyle factors that could reduce the incidence of colorectal cancer in New Zealand. N Z Med J 2016;129(1447):13–20.
Julka M, Cherukuri M, Lameh R. Screening for cancerous and precancerous conditions of the colon. Prim Care 2011;38(3):449–68.
Gandhi J, Davidson C, Hall C, et al. Population-based study demonstrating an increase in colorectal cancer in young patients. Br J Surg 2017;104(8):1063–68.
Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 2015;150(1):17–22.
Done JZ, Fang SH. Young-onset colorectal cancer: A review. World J Gastrointest Oncol 2021;13(8):856–66.
Demb J, Liu L, Murphy CC, et al. Young-onset colorectal cancer risk among individuals with iron-deficiency anaemia and haematochezia. Gut 2020;70(8):1529–37.
Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology 1987;93(5):1009–13.
Oono Y, Fu K, Nakamura H, et al. Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci 2009;54(4):906–09.
Kastrinos F, Syngal S. Inherited colorectal cancer syndromes. Cancer J 2011;17(6):405–15.
Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370(14):1298–306.
Schauer C, Chieng M, Wang M, et al. Artificial intelligence improves adenoma detection rate during colonoscopy. N Z Med J 2022;135(1561):22–30.
Schauer C, Pandey R, Minato Y, et al. Endoscopic submucosal dissection: the first reported experience from a New Zealand centre. N Z Med J 2022;135(1550):121–32.
Winawer SJ, Zauber AG, O’Brien MJ, et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 1993;328(13):901–06.
Te Aho O Te Kahu. Update on Polyp Surveillance Guidelines. Wellington, NZ: Te Aho o Te Kahu; 2020.
Cox B, Bagshaw P, Talbot A, Sneyd MJ. Code of Rights and bowel screening. N Z Med J 2019;132(1497):78–79.
Lawrenson R, Blackmore T. Reducing delay and increasing access to early diagnosis for colorectal cancer. Final Report. University of Waikato; 2021.
Love T, Poynton M, Swansson J. The cost effectiveness of bowel cancer screening in New Zealand: a cost-utility analysis based on pilot results. Sapere Research Group; 2016.
Douma LN, Uiters E, Verweij MF, Timmermans DRM. Autonomous and informed decision-making: The case of colorectal cancer screening. PLoS One 2020;15(5):e0233308.
Yeoman A, Parry S. A survey of colonoscopy capacity in New Zealand’s public hospitals. N Z Med J 2007;120(1258):U2632.
Smith L, Read D, Shanthakumar M, et al. Final Evaluation Report of the Bowel Screening Pilot: Screening Rounds One and Two. Wellington, NZ: Ministry of Health; 2016.
Htun HW, Elwood JM, Ioannides SJ, et al. Investigations and referral for suspected cancer in primary care in New Zealand-A survey linked to the International Cancer Benchmarking Partnership. Eur J Cancer Care (Engl) 2017;26(3).
Hamilton W, Round A, Sharp D, Peters TJ. Clinical features of colorectal cancer before diagnosis: A population-based case-control study. Br J Cancer 2005;93(4):399–405.
Jellema P, van der Windt DA, Bruinvels DJ, et al. Value of symptoms and additional diagnostic tests for colorectal cancer in primary care: Systematic review and meta-analysis. BMJ 2010;340:c1269.
Adelstein BA, Macaskill P, Chan SF, et al. Most bowel cancer symptoms do not indicate colorectal cancer and polyps: A systematic review. BMC Gastroenterol 2011;11:65.
Westwood M, Lang S, Armstrong N, et al. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidance. BMC Med 2017;15(1):189.
National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. (NICE Guideline NG12) London, UK: NICE; 2015.
Mowat C, Digby J, Strachan JA, et al. Impact of introducing a faecal immunochemical test (FIT) for haemoglobin into primary care on the outcome of patients with new bowel symptoms: A prospective cohort study. BMJ Open Gastroenterol 2019;6(1):e000293.

How to Treat

+How to treat

COPD: Prevent, treat and comfort

Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management

Wednesday 26 March 2025, 12:50 AM